Skip to main content
Premium Trial:

Request an Annual Quote

Evotec, Dow AgroSciences Enter Proteomics Service Deal

NEW YORK (GenomeWeb News) – Evotec today announced a collaboration to support the development of compounds in development at Dow AgroSciences.

As part of the deal, Evotec will provide its quantitative chemical proteomics services to "de-convolute phenotypic screening results" obtained by Dow AgroSciences, a wholly owned subsidiary of Dow Chemical.

Financial and other terms were not disclosed.

"This collaboration highlights the broad applicability of Evotec's industry leading chemical proteomics platform to determine cellular target affinities and mechanisms of action on a proteome wide level and in a native context," Mario Polywka, COO of Evotec, said in a statement.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.